Tactile Systems Technology, Inc.
Rank #10Capital ReturnTCMD · Nasdaq · Healthcare
Tactile Systems Technology, Inc. (TCMD) — Rank #10 by gross profitability (GP/assets 0.89) · ROE 8.5% · Piotroski F-Score N/A.
As-of 2026-09-15 · CIK 0001027838 · all metrics point-in-time as of the filing date.
About
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.
Show moreShow less
It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc.
was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
- Industry
- Medical Devices
- Sector
- Healthcare
- State
- MN
- Filer Category
- Accelerated filer
- Fiscal Year End
- December 31
- Website
- tactilemedical.com
Segments
A revenue-by-segment breakdown is not available for TCMD. This is expected for a single-reportable-segment filer with no product/service revenue disaggregation, or for a company whose filings predate SEC’s XBRL viewer.